Comments: NJ A277 | 2020-2021 | Regular Session

Bill Title: Requires public members of Drug Utilization Review Board to disclose financial interests and benefits received from and investment interests held in pharmaceutical distributors, pharmaceutical manufacturers, or pharmacy benefits managers.

Spectrum: Partisan Bill (Democrat 6-0)

Status: (Passed) 2021-11-08 - Approved P.L.2021, c.285. [A277 Detail]

Text: Latest bill text (Chaptered) [HTML]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2020 New Jersey A277 at this time.

Social Comments on NJ A277

feedback